Navigation Links
Biodegradable tooth-binding micelles inhibit Streptococcus mutans biofilm growth
Date:3/19/2011

San Diego, Calif., USA Today, during the 89th General Session & Exhibition of the International Association for Dental Research, held in conjunction with the 40th Annual Meeting of the American Association for Dental Research and the 35th Annual Meeting of the Canadian Association for Dental Research, lead researcher F. Cheni will hold an oral presentation on a research study titled "Biodegradable Tooth-binding Micelles Inhibit Streptococcus mutans (S. mutans) Biofilm Growth."

This research was performed under the objective to develop tooth-binding micelles(TBM) using peptide based biodegradable tooth-binding moieties that can effectively bind to the tooth surface to provide prolonged drug retention in the oral cavity, but can also safely detach from the tooth by gradual degradation of the peptide. Di-phosphoserine, tetra-phosphoserine and hexa-phosphoserine peptides were synthesized using a standard solid phase peptide synthesis method. These oligopeptides were conjugated to Pluronic P123 copolymer using a click reaction.

The tooth-binding micelle was prepared by self-assembly of the modified Pluronics with the antimicrobial agent triclosan. The binding kinetics of TBMs on hydroxyapatite (HA) particles was evaluated using a UV spectrophotometer. For in vitro biofilm prevention studies, HA discs were pretreated with different TBM formulations prior to inoculation with S. mutans UA159, and subsequent biofilm formation was assessed. Biofilm growth was measured by calculating the colony forming units (CFU) recovered per disc. Specific differences between the log-CFU/biofilm of each experimental group were analyzed using the Student t-test. A p-value of < 0.05 was considered as statistically significant.

The binding kinetics of TBMs on HA particles were found to be fast (< 1 min). Higher binding capacity was achieved using tetra- and hexa-phosphoserine as binding moieties. In biofilm prevention study, the TBM treated groups all showed significantly lower CFU (2 to 4-log reduction, p<0.05) per HA disc compared to the control groups.


'/>"/>

Contact: Ingrid L. Thomas
ithomas@iadr.org
703-299-8084
International & American Association for Dental Research
Source:Eurekalert

Related medicine news :

1. Green Genius Biodegradable Plastic Trash Bags Become First And Only Trash Bag Validated As Biodegradable By UL Environment
2. H1N1, Biodegradable Plastics and Nuclear Physics Highlight Research Areas Undertaken During Houghton College's Summer Research Institute
3. University of Michigan scientists identify chemical in bananas as potent inhibitor of HIV infection
4. Patients Who Take a Proton-Pump Inhibitor With Medicine to Prevent Blood Clots Are Less Likely to Be Hospitalized for Bleeding Ulcers
5. BRAF inhibitor shows promising preclinical activity against melanoma
6. Inhibiting fatty acids in immune cells decreases atherosclerosis risk
7. Inhibiting prostate cancer without disturbing regular body processes
8. Double-therapy approach effectively inhibited brain cancer recurrence
9. Selective inhibition of BMK1 suppresses tumor growth
10. JAK inhibitor provides rapid, durable relief for myelofibrosis patients
11. Novel biomarker may predict response to new VEGF receptor inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 2017 , ... At Hallmark Nameplate, their commitment to quality is what sets ... ISO 13485. This certification is another way they are making constant strides to provide ... they need. , The ISO 13485 Certification is a major accomplishment for Hallmark Nameplate ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael ... new website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. ... in the field of biosimilars through thought leader interaction in, live video and ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... problems ranging from gum disease to enamel erosion, and those dental problems can ... Department of Public Health, many pregnant women are failing to get the dental ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – Everyone ... choose the best drug option for each patient. Dentists have several general anesthesia alternatives ... outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted to find ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and researchers ... those who desire a more intimate review and analysis of its highlights, a novel ... Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by Kathy ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017   Spotlight Innovation Inc. (OTCQB: ... in the second quarter of 2017, to launch ... to provide relief from chronic pain, is a ... was developed under a licensing agreement with Dr. ... from snake venom. Additionally, Caretta Therapeutics has signed ...
(Date:1/18/2017)... , Jan 18, 2017 Research and Markets ... Vomiting Drugs Market 2017-2021" report to their offering. ... The global CINV drugs ... 2017-2021. Global Thoracic Surgery Market 2017-2021, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/18/2017)... -- In China , we say Health ... of China,s Healthy Strategy originates. 2016 ... Economic and Social Development of the People,s Republic ... state council of the People,s Republic of China ... development plan, identifying medical devices as one of the main ...
Breaking Medicine Technology: